| Novartis Pharma Schweiz AG - Jadenu 180 mg, Filmtabletten | | 65867 | | 02 | | Jadenu 180 mg | | Filmtabletten | | V03AC03 | | Deferasirox | | 12.01.2017 | | |
| | Composition | | deferasiroxum 180 mg, cellulosum microcristallinum, crospovidonum, povidonum K 30, magnesii stearas, silica colloidalis anhydrica, poloxamerum 188, Überzug: hypromellosum, macrogolum 4000, talcum, E 132, E 171 pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Déférasirox | 180 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Déférasirox | 180 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 132 | | color. | | E 171 | | color. | | Hypromellosum | | Überzug | | Macrogol | 4000 | | | Magnesii Stearas | | | | Poloxamer | 188 | | | Povidonum K | 30 | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| |
|
